Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin MD Kazatchkine, SV Kaveri New England Journal of Medicine 345 (10), 747-755, 2001 | 1488 | 2001 |
Surface hydrophobin prevents immune recognition of airborne fungal spores V Aimanianda, J Bayry, S Bozza, O Kniemeyer, K Perruccio, SR Elluru, ... Nature 460 (7259), 1117-1121, 2009 | 891 | 2009 |
Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies MS Maddur, P Miossec, SV Kaveri, J Bayry The American journal of pathology 181 (1), 8-18, 2012 | 736 | 2012 |
Cutting edge: human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells N Misra, J Bayry, S Lacroix-Desmazes, MD Kazatchkine, SV Kaveri The Journal of Immunology 172 (8), 4676-4680, 2004 | 727 | 2004 |
Self-reactive antibodies (natural autoantibodies) in healthy individuals S Lacroix-Desmazes, SV Kaveri, L Mouthon, A Ayouba, E Malanchère, ... Journal of immunological methods 216 (1-2), 117-137, 1998 | 486 | 1998 |
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin J Bayry, S Lacroix-Desmazes, C Carbonneil, N Misra, V Donkova, ... Blood, The Journal of the American Society of Hematology 101 (2), 758-765, 2003 | 410 | 2003 |
Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. A Nicoletti, S Kaveri, G Caligiuri, J Bariéty, GK Hansson The Journal of clinical investigation 102 (5), 910-918, 1998 | 358 | 1998 |
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis A Ephrem, S Chamat, C Miquel, S Fisson, L Mouthon, G Caligiuri, ... Blood, The Journal of the American Society of Hematology 111 (2), 715-722, 2008 | 341 | 2008 |
Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic … NKA Prasad, G Papoff, A Zeuner, E Bonnin, MD Kazatchkine, G Ruberti, ... The Journal of Immunology 161 (7), 3781-3790, 1998 | 341 | 1998 |
Intravenous immunoglobulin: an update on the clinical use and mechanisms of action VS Negi, S Elluru, S Siberil, S Graff-Dubois, LUC Mouthon, ... Journal of clinical immunology 27, 233-245, 2007 | 334 | 2007 |
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis AE Warrington, K Asakura, AJ Bieber, B Ciric, V Van Keulen, SV Kaveri, ... Proceedings of the National Academy of Sciences 97 (12), 6820-6825, 2000 | 302 | 2000 |
Intravenous immunoglobulins–understanding properties and mechanisms A Durandy, SV Kaveri, TW Kuijpers, M Basta, S Miescher, JV Ravetch, ... Clinical & Experimental Immunology 158 (Supplement_1), 2-13, 2009 | 290 | 2009 |
IVIG-mediated effector functions in autoimmune and inflammatory diseases C Galeotti, SV Kaveri, J Bayry International immunology 29 (11), 491-498, 2017 | 269 | 2017 |
Catalytic activity of anti-thyroglobulin antibodies. L Li, S Paul, S Tyutyulkova, MD Kazatchkine, S Kaveri Journal of immunology (Baltimore, Md.: 1950) 154 (7), 3328-3332, 1995 | 260 | 1995 |
Mechanisms of action of intravenous immune globulin in immune‐mediated diseases L Mouthon, SV Kaveri, SH Spalter, S Lacroix-Desmazes, C Lefranc, ... Clinical & Experimental Immunology 104, 3-9, 1996 | 255 | 1996 |
Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. LJ Emorine, S Marullo, C Delavier-Klutchko, SV Kaveri, ... Proceedings of the National Academy of Sciences 84 (20), 6995-6999, 1987 | 253 | 1987 |
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases J Bayry, N Misra, V Latry, F Prost, S Delignat, S Lacroix-Desmazes, ... Transfusion Clinique et Biologique 10 (3), 165-169, 2003 | 241 | 2003 |
Modulation of the cellular immune system by intravenous immunoglobulin T Tha-In, J Bayry, HJ Metselaar, SV Kaveri, J Kwekkeboom Trends in immunology 29 (12), 608-615, 2008 | 237 | 2008 |
Phosphorylcholine-targeting immunization reduces atherosclerosis G Caligiuri, J Khallou-Laschet, M Vandaele, AT Gaston, S Delignat, ... Journal of the American College of Cardiology 50 (6), 540-546, 2007 | 235 | 2007 |
Internalization of beta-adrenergic receptor in A431 cells involves non-coated vesicles G Raposo, I Dunia, C Delavier-Klutchko, S Kaveri, AD Strosberg, ... European journal of cell biology 50 (2), 340-352, 1989 | 212 | 1989 |